Document Detail


Monitoring and reversal strategies for new oral anticoagulants.
MedLine Citation:
PMID:  25431993     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Thrombin inhibitor dabigatran and factor Xa inhibitors rivaroxaban, apixaban and edoxaban form a new class of non-vitamin K antagonist oral anticoagulants and have been extensively studied in patients with venous thromboembolism and atrial fibrillation. They offer anticoagulation that is as effective and at least as safe compared to warfarin without the need for routine laboratory monitoring; however, no reversal strategies are currently validated in case of a non-vitamin K antagonist oral anticoagulant-associated bleed. In emergency situations, laboratory drug measurement and well-defined management for non-vitamin K antagonist oral anticoagulant-induced hemorrhage may improve clinical outcome. In this review, the merits and limitations of the routine coagulation tests and some of the more specific laboratory assays are compared. Furthermore, prohemostatic measures are reviewed and the recommended strategies in case of bleeding are summarized. Specific reversal agents are currently under development (idarucizumab for dabigatran, andexanet alfa for Xa inhibitors, and PER977 for both Xa- and thrombin inhibitors), which will facilitate clinical management of severe bleeding and emergency surgery.
Authors:
Sophie Vanden Daelen; Marijke Peetermans; Thomas Vanassche; Peter Verhamme; Erik Vandermeulen
Related Documents :
1316113 - Multiple cytomegalovirus-related intestinal perforations in patients with acquired immu...
12497193 - Esophageal actinomycosis: a case report and review of the literature.
22152923 - Intimal aortic sarcoma mimicking ruptured thoracoabdominal type iv aneurysm. a rare cas...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-11-28
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  -     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2014 Nov 
Date Detail:
Created Date:  2014-11-28     Completed Date:  -     Revised Date:  2014-11-29    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-9     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Embodiment and self in reorientation to everyday life following severe traumatic brain injury.
Next Document:  A graphene/zinc oxide nanocomposite film protects dental implant surfaces against cariogenic Strepto...